معرفی
William C. Hahn is the William Rosenberg Professor of Medicine at Harvard Medical School and Executive Vice President/Chief Operating Officer at Dana-Farber Cancer Institute. His laboratory develops functional genomics approaches to identify cancer targets and resistance mechanisms.
Research focuses on defining cooperative oncogenic interactions using genetically engineered cancer models and genome-scale screening platforms. Hahn co-leads the Cancer Dependency Map initiative to systematically identify therapeutic vulnerabilities across cancer types.
Awards
- Richard and Hinda Rosenthal Award (2015)
- Ho-Am Prize in Medicine (2010)
- Howard Temin Award (2001)
- Elected to National Academy of Medicine
His clinical expertise includes prostate cancer and molecularly targeted therapies. Hahn founded multiple biotechnology companies to translate cancer target discoveries.
۰مقاله منتشرشده
